F2 and COVID-19: Reports show COVID‐19 patients present with several coagulopathic abnormalities: elevated D‐dimer, prothrombin time (PT), and activated thromboplastin time (PTT), with associated intraalveolar fibrin deposition and venous thromboembolism.2, 3